Related Experiment Videos
Terminology for carcinoma-in-situ of the breast
Lancet (London, England)
|May 4, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay.
Breast cancer research and treatment·2025
Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
Histopathology·2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Understanding peripheral arterial disease in the current era.
Lancet (London, England)·2026
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.
Lancet (London, England)·2026
Developing roadmaps for advancing practice, research, and policy in the arts and health.
Lancet (London, England)·2026